hypogonadism; oral t therapy; sexual function

*m Mean sexual activity scores rose from 2.43 points at baseline to 4.28 points at day 105 for men receiving oral testosterone undecanoate, a 1.85-point improvement during the trial. “Just to put this in perspective, when we look at the TRAVERSE trial, that change [in sexual activity score] was...